SEC Filings

Filing date	Form	Description	View
05/14/14	3	Initial filing by director officer or owner of more than ten percent	View HTML 0001179110-14-008441.pdf 0001179110-14-008441.rtf 0001179110-14-008441.xls
05/14/14	3	Initial filing by director officer or owner of more than ten percent	View HTML 0001179110-14-008442.pdf 0001179110-14-008442.rtf 0001179110-14-008442.xls
05/09/14	CORRESP	CORRESP	View HTML 0001104659-14-036969.pdf 0001104659-14-036969.rtf 0001104659-14-036969.xls
05/07/14	10-12B/A	Amendment to a previously filed 10-12B	View HTML 0001047469-14-004658.pdf 0001047469-14-004658.rtf 0001047469-14-004658.xls
04/30/14	10-12B/A	Amendment to a previously filed 10-12B	View HTML 0001047469-14-004381.pdf 0001047469-14-004381.rtf 0001047469-14-004381.xls
04/08/14	10-12B/A	Amendment to a previously filed 10-12B	View HTML 0001047469-14-003560.pdf 0001047469-14-003560.rtf 0001047469-14-003560.xls
11/22/13	10-12B/A	Amendment to a previously filed 10-12B	View HTML 0001047469-13-010796.pdf 0001047469-13-010796.rtf 0001047469-13-010796.xls
11/22/13	CORRESP	CORRESP	View HTML 0001104659-13-086671.pdf 0001104659-13-086671.rtf 0001104659-13-086671.xls
11/13/13	UPLOAD	UPLOAD	View HTML 0000000000-13-062336.pdf
10/29/13	10-12B/A	Amendment to a previously filed 10-12B	View HTML 0001047469-13-010050.pdf 0001047469-13-010050.rtf 0001047469-13-010050.xls

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.

Shareholder Tools